TrialBlood2006

Randomized use of cyclosporin A (CsA) to modulate P-glycoprotein in children with AML in remission: Pediatric Oncology Group Study 9421.

David Becton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.